![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MRPL32 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Mrpl32 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of MRPL32 mRNA | CTD | PMID:22206623 | MRPL32 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Mrpl32 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of MRPL32 mRNA] | CTD | PMID:22206623 | MRPL32 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Mrpl32 (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL32 mRNA | CTD | PMID:37844793 | MRPL32 | Human | 2,6-dinitrotoluene | affects expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of MRPL32 mRNA | CTD | PMID:21346803 | MRPL32 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of MRPL32 mRNA | CTD | PMID:21179406 | MRPL32 | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of MRPL32 protein | CTD | PMID:34915118 | MRPL32 | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | Mrpl32 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of MRPL32 mRNA | CTD | PMID:18648102 | MRPL32 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MRPL32 mRNA | CTD | PMID:36041667 | MRPL32 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of MRPL32 mRNA | CTD | PMID:30047161 | MRPL32 | Human | amitrole | increases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of MRPL32 mRNA | CTD | PMID:30047161 | MRPL32 | Human | arsenite(3-) | decreases expression | ISO | Mrpl32 (Mus musculus) | 6480464 | arsenite results in decreased expression of MRPL32 protein | CTD | PMID:37955338 | MRPL32 | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of MRPL32 mRNA | CTD | PMID:22378314 | MRPL32 | Human | bisphenol A | decreases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MRPL32 mRNA | CTD | PMID:25181051 more ... | MRPL32 | Human | bisphenol A | multiple interactions | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MRPL32 mRNA | CTD | PMID:36041667 | MRPL32 | Human | bisphenol A | decreases expression | ISO | Mrpl32 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of MRPL32 mRNA | CTD | PMID:33221593 | MRPL32 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MRPL32 mRNA and bisphenol A results in decreased expression of MRPL32 protein | CTD | PMID:29275510 and PMID:33376534 | MRPL32 | Human | bisphenol F | multiple interactions | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MRPL32 mRNA | CTD | PMID:36041667 | MRPL32 | Human | butan-1-ol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MRPL32 mRNA | CTD | PMID:29432896 | MRPL32 | Human | carbon nanotube | increases expression | ISO | Mrpl32 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | MRPL32 | Human | chromium(6+) | affects expression | ISO | Mrpl32 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of MRPL32 mRNA | CTD | PMID:28472532 | MRPL32 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of MRPL32 mRNA | CTD | PMID:25562108 | MRPL32 | Human | diclofenac | multiple interactions | ISO | Mrpl32 (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL32 mRNA | CTD | PMID:37844793 | MRPL32 | Human | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of MRPL32 mRNA | CTD | PMID:18175754 | MRPL32 | Human | finasteride | increases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of MRPL32 mRNA | CTD | PMID:24136188 | MRPL32 | Human | flutamide | increases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of MRPL32 mRNA | CTD | PMID:24136188 | MRPL32 | Human | folic acid | multiple interactions | ISO | Mrpl32 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of MRPL32 mRNA] | CTD | PMID:22206623 | MRPL32 | Human | gentamycin | decreases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of MRPL32 mRNA | CTD | PMID:33387578 | MRPL32 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of MRPL32 mRNA | CTD | PMID:20044591 | MRPL32 | Human | ibuprofen | multiple interactions | ISO | Mrpl32 (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL32 mRNA | CTD | PMID:37844793 | MRPL32 | Human | isobutanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MRPL32 mRNA | CTD | PMID:29432896 | MRPL32 | Human | ketoconazole | increases expression | EXP | | 6480464 | Ketoconazole results in increased expression of MRPL32 mRNA | CTD | PMID:36621641 | MRPL32 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL32 mRNA | CTD | PMID:31059760 | MRPL32 | Human | methamphetamine | increases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | Methamphetamine results in increased expression of MRPL32 mRNA | CTD | PMID:19149911 | MRPL32 | Human | methimazole | increases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of MRPL32 mRNA | CTD | PMID:30047161 | MRPL32 | Human | mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of MRPL32 mRNA | CTD | PMID:38685446 | MRPL32 | Human | ozone | multiple interactions | ISO | Mrpl32 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MRPL32 mRNA | CTD | PMID:34911549 | MRPL32 | Human | p-toluidine | decreases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | 4-toluidine results in decreased expression of MRPL32 mRNA | CTD | PMID:27638505 | MRPL32 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MRPL32 mRNA | CTD | PMID:25704631 and PMID:31059760 | MRPL32 | Human | paracetamol | multiple interactions | EXP | | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL32 mRNA | CTD | PMID:31059760 | MRPL32 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of MRPL32 mRNA | CTD | PMID:23557933 | MRPL32 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MRPL32 mRNA | CTD | PMID:38568856 | MRPL32 | Human | sulfadimethoxine | increases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of MRPL32 mRNA | CTD | PMID:30047161 | MRPL32 | Human | sulindac | increases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | Sulindac results in increased expression of MRPL32 mRNA | CTD | PMID:24136188 | MRPL32 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of MRPL32 mRNA | CTD | PMID:31758290 | MRPL32 | Human | thalidomide | decreases expression | ISO | Mrpl32 (Mus musculus) | 6480464 | Thalidomide results in decreased expression of MRPL32 mRNA | CTD | PMID:26217789 | MRPL32 | Human | titanium dioxide | decreases methylation | ISO | Mrpl32 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of MRPL32 gene | CTD | PMID:35295148 | MRPL32 | Human | tolcapone | decreases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | tolcapone results in decreased expression of MRPL32 mRNA | CTD | PMID:24136188 | MRPL32 | Human | trichloroethene | decreases expression | ISO | Mrpl32 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of MRPL32 mRNA | CTD | PMID:33387578 | MRPL32 | Human | valproic acid | decreases expression | ISO | Mrpl32 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of MRPL32 mRNA | CTD | PMID:20546886 | |